Visirna Therapeutics Company
Visirna Therapeutics to develop and commercialize RNAi therapeutics targeting cardiovascular and metabolic diseases.
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2022-01-01
Industry:
Advanced BioTech R&D
Employee Number:
51-100
Sub-Industry:
PharmTech
Investors:
Vivo Capital
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China